Mode
Text Size
Log in / Sign up

Review of liquid-liquid phase separation in antibody class switch recombination remains under investigation

Review of liquid-liquid phase separation in antibody class switch recombination remains under invest…
Photo by Logan Voss / Unsplash
Key Takeaway
Note that causal roles of LLPS in CSR remain under active investigation without reported clinical data.

This publication is a narrative review rather than a primary trial or meta-analysis. Its scope focuses on the theoretical and mechanistic role of liquid-liquid phase separation (LLPS) and biomolecular condensation during antibody class switch recombination (CSR) in activated B lymphocytes. The review synthesizes current understanding of these biophysical processes without providing pooled effect sizes or trial-level statistics.

The authors explicitly state that the causal contribution of LLPS in physiological immune contexts remains under active investigation. No specific sample size, setting, or follow-up duration was reported for the evidence discussed. Consequently, no primary or secondary outcome data, nor adverse event rates, are available from this source.

Given the lack of reported quantitative data and the exploratory nature of the topic, the practice relevance is not defined. Clinicians should interpret these findings as mechanistic hypotheses rather than established clinical guidelines. The review does not provide evidence sufficient to alter current management of immune-related conditions based on LLPS mechanisms.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
The spatial and temporal organization of nuclear processes is increasingly interpreted through principles associated with liquid–liquid phase separation (LLPS), whereby multivalent interactions among proteins and nucleic acids generate dynamic, membraneless assemblies. In DNA repair, such assemblies have been proposed to coordinate damage sensing, signaling, and repair pathway choice; however, their causal contribution in physiological immune contexts remains under active investigation. Antibody class switch recombination (CSR) provides a stringent immunological model in which to examine these concepts, as activated B lymphocytes must efficiently rejoin programmed DNA double-strand breaks (DSBs) across long genomic distances while suppressing aberrant chromosomal rearrangements. Emerging evidence indicates that CSR involves dynamic RNA–protein assemblies enriched for 53BP1, heterogeneous nuclear ribonucleoproteins such as HNRNPU, and transcription-associated RNA scaffolds, with properties consistent with biomolecular condensation. These assemblies are proposed to function as a CSR-specific regulatory hub—or “switchosome”—that concentrates non-homologous end joining factors, enforces repair pathway choice, and integrates transcription, RNA structure, and chromatin architecture at immunoglobulin heavy-chain (IgH) switch regions. Rather than treating LLPS as universally established, this review critically evaluates experimental evidence supporting condensate-like behavior in CSR-associated repair compartments, distinguishing demonstrated mechanisms from LLPS-consistent or speculative models. We further discuss how disruption of condensate dynamics—either through impaired assembly or pathological stabilization—can compromise repair fidelity, contributing to immunodeficiency and B cell lymphomagenesis. By positioning CSR as a paradigm for studying higher-order nuclear organization during programmed genome rearrangements, this review highlights how condensate-based regulation may contribute to immune diversification and genome stability.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.